At the human level, a similar increase in PPARγ levels has recently been described in the CSF of patients with definite MS, correlating with inflammatory CSF alterations, such as IgG index and leukocyte cell count, and demonstrating an association with increased disease severity [120]. Here, PPARG is linked to myeloid sarcoma.